Anna Pous

602 total citations
7 papers, 61 citations indexed

About

Anna Pous is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Infectious Diseases. According to data from OpenAlex, Anna Pous has authored 7 papers receiving a total of 61 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 3 papers in Radiology, Nuclear Medicine and Imaging and 2 papers in Infectious Diseases. Recurrent topics in Anna Pous's work include HER2/EGFR in Cancer Research (3 papers), Monoclonal and Polyclonal Antibodies Research (3 papers) and SARS-CoV-2 and COVID-19 Research (2 papers). Anna Pous is often cited by papers focused on HER2/EGFR in Cancer Research (3 papers), Monoclonal and Polyclonal Antibodies Research (3 papers) and SARS-CoV-2 and COVID-19 Research (2 papers). Anna Pous collaborates with scholars based in Spain. Anna Pous's co-authors include Eudald Felip, Mireia Margelí Vila, Cinta Hierro, Cristina Bugés, Laura Layos, Óscar Vilarroya, Xavier Guell, Clara Pretus, Teresa Morán and Víctor Pérez and has published in prestigious journals such as International Journal of Molecular Sciences, Cancers and Journal of Thoracic Oncology.

In The Last Decade

Anna Pous

6 papers receiving 61 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anna Pous Spain	4	38	19	15	10	7	7	61
Amy Lew Tsuhako United States	2	33 0.9×	11 0.6×	19 1.3×	10 1.0×	7 1.0×	2	49
Hwoei Fen Soo Hoo Malaysia	3	27 0.7×	14 0.7×	7 0.5×	10 1.0×		4	37
Adrienne E. Borrie Canada	6	40 1.1×	14 0.7×	15 1.0×	3 0.3×	4 0.6×	6	77
Arkom Chaiwerawattana Thailand	5	60 1.6×	9 0.5×	28 1.9×	9 0.9×	3 0.4×	8	116
Samuel M. Rubinstein United States	5	42 1.1×	13 0.7×	16 1.1×	6 0.6×	12 1.7×	10	68
Laura Leroy France	3	28 0.7×	18 0.9×	4 0.3×	5 0.5×	3 0.4×	8	36
Eva Sum Germany	3	34 0.9×	8 0.4×	11 0.7×	9 0.9×	1 0.1×	7	59
Reyes Bernabé Spain	4	54 1.4×	50 2.6×	17 1.1×	8 0.8×	2 0.3×	10	71
Yuko Tanabe Japan	3	35 0.9×	17 0.9×	11 0.7×	3 0.3×	5 0.7×	6	46
Archana Ajmera United States	3	36 0.9×	38 2.0×	18 1.2×	9 0.9×		13	49

Countries citing papers authored by Anna Pous

Since Specialization

Citations

This map shows the geographic impact of Anna Pous's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Pous with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Pous more than expected).

Fields of papers citing papers by Anna Pous

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Pous. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Pous. The network helps show where Anna Pous may publish in the future.

Co-authorship network of co-authors of Anna Pous

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Pous. A scholar is included among the top collaborators of Anna Pous based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Pous. Anna Pous is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Pous, Anna, Adrià Bernat‐Peguera, Beatriz Cirauqui, et al.. (2024). Deciphering HER2-low breast cancer (BC): insights from real-world data in early stage breast cancer. Therapeutic Advances in Medical Oncology. 16. 12735456–12735456.

2.

Pous, Anna, et al.. (2023). HER2-Positive Gastric Cancer: The Role of Immunotherapy and Novel Therapeutic Strategies. International Journal of Molecular Sciences. 24(14). 11403–11403. 21 indexed citations

3.

Hernández, Ainhoa, Eudald Felip, Marc Cucurull, et al.. (2022). Immune Response and Effects of COVID-19 Vaccination in Patients with Lung Cancer—COVID Lung Vaccine Study. Cancers. 15(1). 137–137. 4 indexed citations

4.

Quirant‐Sánchez, Bibiana, Eudald Felip, Maria Saigí, et al.. (2022). OA06.04 Immune Response after SARS-CoV-2 Vaccination in Lung Cancer Patients. Update of the Covid Lung Vaccine Cohort. Journal of Thoracic Oncology. 17(9). S18–S18. 1 indexed citations

5.

Felip, Eudald, et al.. (2022). Targeted Therapeutic Options and Future Perspectives for HER2-Positive Breast Cancer. Cancers. 14(14). 3305–3305. 25 indexed citations

6.

Pous, Anna, et al.. (2021). Immune-checkpoint inhibitors for lung cancer patients amid the COVID-19 pandemic: a case report of severe meningoencephalitis after switching to an extended-interval higher flat-dose nivolumab regimen. Translational Lung Cancer Research. 10(4). 1917–1923. 3 indexed citations

7.

Bergé, Daniel, Clara Pretus, Xavier Guell, et al.. (2018). Reduced willingness to invest effort in schizophrenia with high negative symptoms regardless of reward stimulus presentation and reward value. Comprehensive Psychiatry. 87. 153–160. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact